Agilon Health

AGL

Market cap $446M

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the first quarter 2026 after market close on Wednesday, May 6, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and +1 (585) 542-9983 for international participants and referenc.

PHILADELPHIA, March 31, 2026 (GLOBE NEWSWIRE) -- Stockholder rights firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE: AGL) (“Agilon”) on behalf of the company's long-term investors.  Click here for additional information:  https://kaskelalaw.com/case/agilon-health/      Recently a securities fraud complaint was filed against Agilon on behalf of certain investors who purchased shares of the company's stock between April 15, 2021 and February 27, 2024.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL) (the “Company”), the trusted partner empowering physicians to transform health care in our communities, today announced that it will implement a reverse stock split (the “Reverse Stock Split”) of the Company's common stock, par value $0.01 per share (the “Common Stock”), at a ratio of 1-for-25. The reverse stock split is expected to become effective on March 30, 2026, on or around 5:01 p.m. Eastern Time (“Effective Time”) and a.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

agilon health, inc. (AGL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

NEW YORK, March 5, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Agilon Health, Inc. (NYSE: AGL)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Agilon Health caused the company to misrepresent or fail to disclose that: 1) guidance for 2025 was recklessly issued because that they knew or should have known it was not going to be achieved; (2) the immediate positive financial impact from strategic actions taken by Agilon to reduce risk was materially overstated; and (3) as a result, statements about the Company's business, operations, and prospects were materially false and/or misleading at relevant times.

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc.

LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK--(BUSINESS WIRE)---- $AGL #AGL--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.